Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −2,000 18,000
2024-01-30 Hansen Gwenn Chief Scientific Officer Option exercise +3,207 36,736
2024-01-30 Hansen Gwenn Chief Scientific Officer Option exercise +2,000 38,736
2024-01-30 Hansen Gwenn Chief Scientific Officer Sale −2,334 $7.99 $19K 36,402
2024-01-30 Hansen Gwenn Chief Scientific Officer Option exercise · Restricted Stock Units −3,207 25,654
2024-01-30 Hansen Gwenn Chief Scientific Officer Option exercise · Restricted Stock Units −2,000 18,000
2024-01-30 Ring Christine Chief Legal Officer Option exercise +1,924 17,187
2024-01-30 Ring Christine Chief Legal Officer Option exercise +2,000 19,187
2024-01-30 Ring Christine Chief Legal Officer Sale −1,760 $7.99 $14K 17,427
2024-01-30 Ring Christine Chief Legal Officer Option exercise · Restricted Stock Units −1,924 15,393
2024-01-30 Ring Christine Chief Legal Officer Option exercise · Restricted Stock Units −2,000 18,000
2023-12-20 van Houte Hans Chief Financial Officer Sale 10b5-1 −3,541 $10.00 $35K 71,930
2023-12-19 van Houte Hans Chief Financial Officer Sale 10b5-1 −10,906 $10.00 $109K 75,471
2023-10-31 van Houte Hans Chief Financial Officer Sale −1,080 $5.20 $6K 86,377
2023-10-31 Ring Christine Chief Legal Officer Sale −1,232 $5.20 $6K 15,263
2023-10-31 Hansen Gwenn Chief Scientific Officer Sale −1,633 $5.20 $8K 33,529
2023-10-30 van Houte Hans Chief Financial Officer Option exercise +2,886 85,457
2023-10-30 van Houte Hans Chief Financial Officer Option exercise +2,000 87,457
2023-10-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −2,886 25,975
2023-10-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −2,000 20,000

Page 23 of 32 · 632 trades